Prescription drug

Anti-PCSK9 antibodies

Prescription drug.

How to take it

There is no established standard dose for this case; it is advisable to consult a professional.

Safety

Prescription drug (injectable); requires a physician.

Effect by goal · level of evidence

High cholesterol (hypercholesterolemia)

reduces Very high meta-analysis (AAA)

Meta-analysis of trials: antibodies against PCSK9 (e.g., evolocumab, alirocumab) greatly lower LDL cholesterol when added to statins and reduce mortality. It is a prescription injectable drug, not a supplement.

View the study (meta-analysis) →

In depth

Drug · Highest evidence: Very high · 1 finding

⚠️ Prescription drug (injectable); requires a physician.

Findings

High cholesterol (hypercholesterolemia) — reduces (Very high, meta-analysis). Meta-analysis of trials: antibodies against PCSK9 (e.g., evolocumab, alirocumab) greatly lower LDL cholesterol when added to statins and reduce mortality. It is an injectable prescription drug, not a supplement. 25915661

Information, not medical advice. Prescription drugs require a doctor.

Information, not medical advice. Scientific evidence reflects the quality of the studies.